Cerner Corporation Underwhelms in the Fourth Quarter

MarketsMotley Fool

Cerner Corporation's (NASDAQ: CERN) third-quarter results announced in October were just so-so. Although the healthcare technology company reported both revenue and earnings increases, the performance wasn't impressive. However, management projected a little better growth for the fourth quarter.

So when Cerner provided its fourth-quarter update after the market closed on Tuesday, investors were eager to find out if the company was able to deliver better results. However, it again underwhelmed. Here are the highlights from Cerner's fourth-quarter performance.

Continue Reading Below

Cerner results: The raw numbers

What happened with Cerner this quarter?

First, the bad news. In its third-quarter update, Cerner projected fourth-quarter revenue between $1.3 billion and $1.35 billion. The company delivered, but just barely. However, Cerner's actual adjusted earnings per share in the fourth quarter fell below its guidance of $0.60 to $0.62. Even worse, adjusted EPS declined from the prior-year period.

The good news was that Cerner posted a huge increase in GAAP net income in the fourth quarter. There is a catch, though. Nearly all of the improvement stemmed from an income tax benefit of $115 million compared to an income tax expense of $66 million in the prior-year period. The fourth-quarter tax benefit included Cerner's current estimates of the impact of U.S. tax reform enacted in December 2017.

Perhaps the best news, though, was that Cerner recorded bookings in the fourth quarter of $2.329 billion. That's an all-time high, and it reflects a year-over-year increase of 62%. Bookings represent the amount of prospective revenue from contracts signed but not yet implemented. Cerner's sales backlog at the end of the fourth quarter stood at $17.55 billion, up 10% over the prior-year period.

The company reported operating cash flow of $348.9 million during the fourth quarter. The company generated free cash flow during the period totaling $185.1 million. As of Dec. 31, 2017, Cerner had a cash position of $805.8 million, including cash, cash equivalents, and short-term investments.

What management had to say

Cerner president Zane Burke put a positive spin on the company's fourth-quarter performance. He said:

Looking forward

How is the current quarter shaping up? Cerner expects first-quarter 2018 revenue between $1.315 billion and $1.365 billion. That reflects roughly 7% year-over-year growth at the mid-point of the range. The company also projects first-quarter adjusted diluted EPS between $0.57 and $0.59. In the same quarter of 2017, Cerner reported adjusted diluted EPS of $0.59.

As for full-year 2018, Cerner projects revenue between $5.45 billion and $5.65 billion. That translates to year-over-year growth of around 8% at the mid-point of the range. However, the full-year revenue guidance was a little lower than the company's preliminary outlook provided three months ago. Full-year 2018 adjusted diluted EPS is expected to come in between $2.57 and $2.73, an 11% increase from 2017.

Investors will certainly want to watch to see what changes new CEO Brent Shafer might make. Shafer took the helm on Feb. 1, 2018. He previously served as CEO of Philips North America, part of Dutch technology company Koninklijke Philips NV. Shafer helped Philips increase profitability and expand market share -- just what Cerner shareholders would love to see in the years ahead.

10 stocks we like better than CernerWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Cerner wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of February 5, 2018

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Cerner. The Motley Fool has a disclosure policy.

Continue Reading Below